Cancer iChart

Cancer iChart

Free
Black friday sale icon
Ready for Black Friday?
Click to generate a QR code for easy access to the app on the App Store
Rating summary

Details about Cancer iChart

  • Released
  • Updated
  • iOS Version
  • Age Rating
  • Size
  • Devices
  • Languages

Features

Developer of Cancer iChart

Cancer iChart screenshot #1 for iPhone
Cancer iChart screenshot #2 for iPhone
Cancer iChart screenshot #3 for iPhone
Cancer iChart screenshot #4 for iPhone
Cancer iChart screenshot #5 for iPhone
iphone
ipad
🙌0
Ratings
🗣❌ unsupported
Your locale
🖼️Download
Icons↘︎

Version History of Cancer iChart

1.0.1

November 1, 2023

- Minor updates around archiving of website.

1.0.0

August 25, 2018

This app has been updated by Apple to display the Apple Watch app icon.

Price History of Cancer iChart

Description of Cancer iChart

Healthcare professionals and patients should use this application to search for potential drug-drug interactions between anti-cancer drugs and other medications. Results are presented as a “Traffic Light” system (red, amber, yellow and green) to indicate the recommendation. A brief summary of each interaction is given along with a grading of the quality of evidence (very low, low, moderate, high). The application is available free of charge and has been developed by Radboudumc in Nijmegen, the Liverpool Drug Interactions Group at the University of Liverpool and Clubzap Ltd. Requirements:
This is an “offline” application that is downloaded to your device. An internet connection is not required to use the application, but is needed for downloading updates.

 Why this application may be useful: Patients with cancer often take medication in addition to cancer therapy either to aid side effects and symptoms, or to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different anti-cancer drugs and other medications that the cancer patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.cancer-druginteractions.org
Show less

Cancer iChart: FAQ

Is the software for Cancer iChart compatible with iPads?

Yes, Cancer iChart works on iPad devices.

Who released the Cancer iChart app?

The Cancer iChart app was developed by Liverpool Drug Interactions Group.

What is the minimum iOS version supported by Cancer iChart?

Cancer iChart currently supports iOS 10.0 or later.

How do users rate the app?

There are no ratings available for Cancer iChart at the moment.

What is the primary genre of the Cancer iChart app?

The Primary Genre Of The Cancer Ichart App Is Medical.

What is the newest version of Cancer iChart?

The latest version of the Cancer iChart app is 1.0.1.

What date was the latest Cancer iChart update?

The latest Cancer iChart update was rolled out on November 30, 2024.

What was the Cancer iChart release date?

The Cancer iChart app launched on February 5, 2023.

What is the content advisory rating of the Cancer iChart app?

Some content may be inappropriate for children under 12, recommended for ages 12 and up.

What languages does Cancer iChart support?

You can use the Cancer iChart app in English.

Is Cancer iChart part of the Apple Arcade gaming experience?

No, Cancer iChart is not on Apple Arcade.

Is Cancer iChart integrated with in-app purchases?

No, Cancer iChart does not integrate in-app purchases for users.

Does Cancer iChart support Apple Vision Pro compatibility?

No, Cancer iChart does not support compatibility with Apple Vision Pro.

Does Cancer iChart incorporate ads within the app?

No, Cancer iChart does not incorporate ads within the app.

Alternatives to Cancer iChart

More Applications by Liverpool Drug Interactions Group